Comprehensive genomic profiling identifies a novel TNKS2-PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy. Blood cancer journal Chalmers, Z. R., Ali, S. M., Ohgami, R. S., Campregher, P. V., Frampton, G. M., Yelensky, R., Elvin, J. A., Palma, N. A., Erlich, R., Vergilio, J., Chmielecki, J., Ross, J. S., Stephens, P. J., Hermann, R., Miller, V. A., MILES, C. R. 2015; 5

View details for DOI 10.1038/bcj.2014.95

View details for PubMedID 25658984